ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106995; 2) Community: the network communities that were significantly associated with the response to NSC 106995; 3) Molecule: the relationships between components within communities and NSC 106995; 4) MDR: the compounds that were significantly associated with the NSC 106995.

NSC Compound Enrichment Correlation
NSC 302991 Camptothecin Derivative 0.0152653588725063 0.38676128
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0152653588725063 0.45873217
NSC 4320 .beta.-k-Strophanthin 0.0152653588725063 0.23649603
NSC 650012 Null 0.0152653588725063 0.16296717
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.0152653588725063 0.42976888
NSC 676773 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-[3-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-6-deoxy-.beta.-D-gulopyranosyl]- .beta 0.0152653588725063 -0.25291206
NSC 678404 Null 0.0152653588725063 0.15032447
NSC 692581 Null 0.0152653588725063 0.26697676
NSC 711615 Null 0.0152653588725063 0.21620172
NSC 734307 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide 0.0152653588725063 0.21734647
Total:57  Current:18    [First] [Prev] [Next] [Last]